Adrian is a seasoned IP lawyer who relishes immersing himself in his client’s technology, product roadmap and patent/IP strategy. He is regularly involved in the negotiation and drafting of technology licence agreements and other contracts with a heavy IP element, such as R&D collaborations, joint ventures, grant funding agreements and other commercial arrangements. He also advises on the EC and UK competition law aspects of these agreements, and issues relating to technical standardisation, essential IPR and patent pooling.

Adrian has a wealth of experience in handling the IP aspects of University spin-outs, IPOs and other major corporate transactions and disputes, including for FTSE 100 and Fortune 500 corporations. He is also a valued patent litigator, having recently advised on disputes involving pharmaceuticals, somatic cell therapy, semiconductor chip design, inkjet printing technology, digital compression algorithms, LCD flat-panel technology, telecoms and pharmaceuticals. He also frequently helps clients with disputes involving confidential information, database rights, trade marks, copyright and designs.

Adrian publishes and speaks regularly on a variety of intellectual property issues.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Technologie, Médias et Communications (TMC)

Transceiver - Autumn 2020

13 octobre 2020
QUICK READ

par plusieurs auteurs

Cliquer ici pour en savoir plus
petri-dish
Coronavirus

Adrian Toutoungi, Josef Fuss and Matt Caskie discuss how biotech has managed its finances during the pandemic

4 septembre 2020

par Adrian Toutoungi et Josef Fuss

Cliquer ici pour en savoir plus
lady-justice
Brevets et innovation

Supreme Court decision in Unwired Planet v Huawei and Conversant v Huawei and ZTE

26 août 2020
QUICK READ

par plusieurs auteurs

Cliquer ici pour en savoir plus
robot-thinking
Technologie, Médias et Communications (TMC)

Advising on the sale of Cambridge AI company SciBite to Elsevier

21 août 2020

par plusieurs auteurs

Cliquer ici pour en savoir plus